Cargando…

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

SIMPLE SUMMARY: We present the long-term results of patients receiving allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory mantle cell lymphoma (R/R MCL) in the last 25 years in Spain. We conclude that allo-SCT may be a curative option in R/R MCL with a low cumulative incidence (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutierrez, Antonio, Bento, Leyre, Novelli, Silvana, Martin, Alejandro, Gutierrez, Gonzalo, Queralt Salas, Maria, Bastos-Oreiro, Mariana, Perez, Ariadna, Hernani, Rafael, Cruz Viguria, Maria, Lopez-Godino, Oriana, Montoro, Juan, Piñana, Jose Luis, Ferra, Christelle, Parody, Rocio, Martin, Carmen, Español, Ignacio, Yañez, Lucrecia, Rodriguez, Guillermo, Zanabili, Joud, Herrera, Pilar, Varela, Maria Rosario, Sampol, Antonia, Solano, Carlos, Caballero, Dolores
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179246/ https://www.ncbi.nlm.nih.gov/pubmed/35681653 http://dx.doi.org/10.3390/cancers14112673

Ejemplares similares

Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
por: Rey-Búa, Beatriz, et al.
Publicado: (2022)

Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
por: Bastos-Oreiro, Mariana, et al.
Publicado: (2022)

COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
por: Ljungman, Per, et al.
Publicado: (2021)

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
por: García-Sancho, Alejandro Martín, et al.
Publicado: (2022)

P1128: CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CASTLEMAN DISEASE: A SPANISH MULTICENTRIC STUDY OF 134 PATIENTS FROM GELTAMO
por: Navarro, J. T., et al.
Publicado: (2022)

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups
por: Ribera, Josep-Maria, et al.
Publicado: (2020)

P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA-C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG-TERM RESULTS OF THE GELTAMO GROUP BRESHAP STUDY
por: Garcia-Sanz, R., et al.
Publicado: (2022)

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
por: Ljungman, Per, et al.
Publicado: (2020)

COVID-19 in Children Following Hematopoietic Cell Transplantation: A Multinational Study of the European Bone Marrow Transplantation Society (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH)
por: Averbuch, Diana, et al.
Publicado: (2021)

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2017)

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma
por: González-Barca, Eva, et al.
Publicado: (2018)

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
por: Sancho, Juan‐Manuel, et al.
Publicado: (2021)

Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
por: López-Sánchez, Cristina, et al.
Publicado: (2020)

Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation
por: Bento, Leyre, et al.
Publicado: (2022)

PB2329: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL): MULTICENTRIC REVIEW OF CLINICAL FEATURES AND TREATMENT: ON BEHALF OF GELTAMO (GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTES DE MÉDULA ÓSEA)
por: Infante, Maria Stefania, et al.
Publicado: (2023)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Esquirol, Albert, et al.
Publicado: (2021)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
por: Bailén, Rebeca, et al.
Publicado: (2023)

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
por: Garcia-Recio, Marta, et al.
Publicado: (2016)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023)

Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
por: Delgado Sánchez, Olga, et al.
Publicado: (2019)

Human Vaccines & Immunotherapeutics awards Top Reviewer of the Year
por: Ellis, Ronald, et al.
Publicado: (2013)

Fermented Aloreña Table Olives as a Source of Potential Probiotic Lactobacillus pentosus Strains
por: Montoro, Beatriz Pérez, et al.
Publicado: (2016)

Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
por: Garcia-Recio, Marta, et al.
Publicado: (2018)

Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment
por: Kaimala, Suneesh, et al.
Publicado: (2018)

Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors
por: Montoro, Juan, et al.
Publicado: (2016)

Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study
por: Mussetti, Alberto, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma
por: Herraez, Ines, et al.
Publicado: (2020)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
por: Salas, Maria Queralt, et al.
Publicado: (2022)

Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study
por: Averbuch, Dina, et al.
Publicado: (2023)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
por: Piñana, José Luis, et al.
Publicado: (2019)

Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)
por: Moreno, Celia, et al.
Publicado: (2023)

Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
por: He, Mengni, et al.
Publicado: (2020)

Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens
por: Piñana, José Luis, et al.
Publicado: (2020)

Allergic mechanisms and immunotherapeutic strategies /
Publicado: (1997)

Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011)

Human Vaccines and Immunotherapeutics: News
por: Riedmann, Eva M
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jfaihqev68dd0gp96tubuaqn6s